We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 2,061 results
  1. Die Rolle der Systemtherapie bei Lungenmetastasen mit Lymphknotenbefall

    Modern systemic therapy with chemotherapy, targeted therapy and immunotherapy has led to a significant improvement in the overall survival in many...

    Yon-Dschun Ko in Wiener klinisches Magazin
    Article 22 April 2020
  2. Die Rolle der Systemtherapie bei Lungenmetastasen mit Lymphknotenbefall

    Modern systemic therapy with chemotherapy, targeted therapy and immunotherapy has led to a significant improvement in the overall survival in many...

    Y.-D. Ko in Der Chirurg
    Article 19 November 2019
  3. Lymphadenektomie

    Felix Preisser, Derya Tilki in Uro-News
    Article 08 March 2023
  4. Organ- und Fertilitätserhalt beim Zervixkarzinom

    Preservation of fertility is important for a significant proportion of patients with cervical cancer. If the disease is diagnosed at an early stage...

    Gerhard Gebauer in Die Onkologie
    Article 26 July 2023
  5. Adjuvante Mediastinalbestrahlung bei nichtkleinzelligem Lungenkarzinom (pN2)

    Background

    Patients with non-small-cell lung cancer (NSCLC) have a high risk for develo** mediastinal relapse. Although adjuvant chemotherapy is the...

    E. Gkika, T. Schimek-Jasch, H. Hoffmann in Die Onkologie
    Article 03 November 2022
  6. Teile (ein) und (be-)herrsche

    Christian Doehn in Uro-News
    Article 08 March 2023
  7. Indikationen zur selektiven Lymphknotenentfernung bzw. systematischen Lymphknotendissektion axillär, inguinal und iliakal

    Lymphadenectomy is a surgical procedure in which lymph nodes are surgically resected. It is usually carried out for oncological surgical treatment of...

    Alperen S. Bingoel, Peter M. Vogt in Die Chirurgie
    Article 01 November 2022
  8. Was ist gesichert in der Prävention, Diagnostik und Therapie des frühen Mammakarzinoms?

    With more than 2.3 million newly diagnosed cases worldwide in 2020, breast cancer is still the most frequent cancer in women and despite improved...

    Elna Kuehnle, Marlene Röttger, Tjoung-Won Park-Simon in Die Innere Medizin
    Article 30 October 2023
  9. Multimodale Therapie des Hochrisiko- und lokal fortgeschrittenen Prostatakarzinoms

    Treatment of the high-risk and locally advanced prostate cancer is a challenge in daily practice. At 20–40%, patients with such tumor stages...

    Felix Preisser, Derya Tilki in Die Urologie
    Article 21 November 2022
  10. Diagnostik und Therapie des Vulva- und des Vaginalkarzinoms

    Vulvar cancer represents the fourth most common cancer of the female genital region with a standardized morbidity rate of 4.4/100,000 women in...

    Tanja Nadine Schlaiß, Christine Wulff, Achim Wöckel in Die Onkologie
    Article 14 April 2023
  11. Adjuvante Strahlentherapie des Mammakarzinoms

    Adjuvant radiotherapy is an integral part of multimodal therapy for early breast cancer. It contributes to the reduction of local recurrences across...

    Tim Lange, Anne Caroline Knöchelmann, Michael Bremer in Die Radiologie
    Article 15 August 2023
  12. Diagnosestellung eines „cancer of unknown primary“

    Background

    With an incidence of 1–3% of all malignancies, cancer of unknown primary (CUP) remains a relevant tumor entity. It is defined by...

    Gerdt Hübner in Die Onkologie
    Article 08 February 2024
Did you find what you were looking for? Share feedback.